Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleCELLULAR AND MOLECULAR

Agonist Activity of the δ-Antagonists TIPP and TIPP-ψ in Cellular Models Expressing Endogenous or Transfected δ-Opioid Receptors

Nancy A. Martin, Maguerite T. Terruso and Paul L. Prather
Journal of Pharmacology and Experimental Therapeutics July 2001, 298 (1) 240-248;
Nancy A. Martin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maguerite T. Terruso
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul L. Prather
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

A new class of highly selective δ-opioid receptor antagonists has been recently developed, termed the TIP(P) peptides. Two prototypical compounds in this class are TIPP (H-Tyr-Tic-Phe-Phe-OH) and a derivative, TIPP-ψ (H-Tyr-Tic[CH2NH]-Phe-Phe-OH). Surprisingly, both TIPP and TIPP-ψ demonstrated inhibition of adenylyl cyclase activity in GH3 cells transfected with δ-opioid receptors (GH3DORT), an effect normally observed by agonists. The agonist activity was δ-selective, because no inhibition occurred in wild-type GH3 or GH3MOR (μ-opioid receptor) cells. Both TIPP and TIPP-ψ exhibited concentration-dependent inhibition of adenylyl cyclase activity; however, TIPP-ψ was found to be less potent (IC50 = 3.97 versus 0.162 nM) and less efficacious (Imax = 50% versus 70%) than TIPP. Pretreatment of cells with pertussis toxin attenuated the inhibition of maximally effective concentrations of TIPP and TIPP-ψ, indicating the involvement of Giα/Goα G-proteins. Other δ-antagonists, naltriben, naloxone, and ICI 174864, attenuated the inhibition of adenylyl cyclase activity mediated by TIPP. Coadministration of TIPP with the selective δ-agonist [d-Pen2,5]enkephalin resulted in an additive interaction. Both TIPP and TIPP-ψ exhibited significant inhibition of adenylyl cyclase activity in different GH3DORT clones expressing a 28-fold range of δ-opioid receptor densities, and in cell lines expressing endogenous (i.e., N1E115 and NG108-15) and transfected (i.e., Chinese hamster ovary-DOR and human embryonic kidney-DOR) δ-opioid receptors, with densities ranging from 0.12 to 6.67 pmol/mg. These results suggest that compounds previously thought to be purely δ-opioid receptor antagonists also demonstrate agonist activity in several in vitro models.

Footnotes

  • This work was supported in part by the National Institute on Drug Abuse Grant DA10936 (to P.L.P.), by The American Heart Association-Heartland Affiliate (to N.A.M.), and by the University of Arkansas for Medical Sciences Graduate Student Research Fund (to N.A.M).

  • Abbreviations:
    Aib
    α-aminoisobutyric acid
    TIPP
    H-Tyr-Tic-Phe-Phe-OH
    TIPP-ψ
    H-Tyr-Tic[CH2NH]-Phe-Phe-OH
    DMSO
    dimethyl sulfoxide
    DPDPE
    [d-Pen2,5]enkephalin
    DMEM
    Dulbecco's modified Eagle's medium
    MOR
    μ-opioid receptor
    MORDOR
    μ- and δ-opioid receptors
    CHO
    Chinese hamster ovary
    HEK
    human embryonic kidney
    DOR
    δ-opioid receptor
    DORT
    tagged δ-opioid receptor
    PTX
    pertussis toxin
    ANOVA
    analysis of variance
    • Received December 29, 2000.
    • Accepted April 3, 2001.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 298 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 298, Issue 1
1 Jul 2001
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Agonist Activity of the δ-Antagonists TIPP and TIPP-ψ in Cellular Models Expressing Endogenous or Transfected δ-Opioid Receptors
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleCELLULAR AND MOLECULAR

Agonist Activity of the δ-Antagonists TIPP and TIPP-ψ in Cellular Models Expressing Endogenous or Transfected δ-Opioid Receptors

Nancy A. Martin, Maguerite T. Terruso and Paul L. Prather
Journal of Pharmacology and Experimental Therapeutics July 1, 2001, 298 (1) 240-248;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleCELLULAR AND MOLECULAR

Agonist Activity of the δ-Antagonists TIPP and TIPP-ψ in Cellular Models Expressing Endogenous or Transfected δ-Opioid Receptors

Nancy A. Martin, Maguerite T. Terruso and Paul L. Prather
Journal of Pharmacology and Experimental Therapeutics July 1, 2001, 298 (1) 240-248;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Experimental Procedures
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • pH-dependent GPR4 antagonist
  • Antifibrotic DRD1 escapes TGFβ-mediated repression
  • Chlorogenic Acid Inhibits Breast Cancer Metastasis
Show more Cellular and Molecular

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics